Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023
Virology · 2023
DOI: 10.1016/j.virol.2023.109869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virology, 2023. Verfasst von Il-Hwan Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, Sout…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
The Korea Disease Control and Prevention Agency (KDCA) has been conducting national genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). To monitor and characterize circulating SARS-CoV-2 variants in South Korea, 102,873 oropharyngeal/nasopharyngeal swab samples collected from patients with confirmed COVID-19 were sequenced, assigned lineages, and phylogenetically analyzed. Each wave followed a pattern of variants emerging first abroad and then spreading domestically. In 2020, B.41 lineage led the first wave, and B.1.497 dominated the second and third waves. In 2021, the fourth wave was driven by Delta (AY.69 and AY.122.5). In 2022, the fifth to seventh waves were dominated by Omicron sub-lineages BA.1/BA.1.1 and BA.2/BA.2.3, BA.5/BA.5.2, and BN.1, sequentially. The KDCA detected and monitored increasing variants in advance prior to large-scale epidemics, but the repeated emergence of new variants could threaten public health again. Therefore, it is important to continue to monitor and characterize emerging and circulating variants through national genomic surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, South Korea.
- Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Cheongju, South Korea. Electronic address: ekim@korea.kr.
Förderung
- Korea Disease Control and Prevention Agency
Zitieren
APA
Kim, I. H., No, J. S., Kim, J. A., Park, A. K., Lee, H., Kim, J. M., Lee, N. J., Kim, C. K., Lee, C. Y., Woo, S., Lee, J., Rhee, J., & Kim, E. J. (2023). Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023. Virology. https://doi.org/10.1016/j.virol.2023.109869
Vancouver
Kim IH, No JS, Kim JA, Park AK, Lee H, Kim JM, et al. Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023. Virology. 2023. doi:10.1016/j.virol.2023.109869
BibTeX
@article{Kim2023,
author = {Kim, Il-Hwan and No, Jin Sun and Kim, Jeong-Ah and Park, Ae Kyung and Lee, HyeokJin and Kim, Jeong-Min and Lee, Nam-Joo and Kim, Chi-Kyeong and Lee, Chae Young and Woo, SangHee and Lee, Jaehee and Rhee, JeeEun and Kim, Eun-Jin},
title = {Genomic epidemiology of SARS-CoV-2 variants in South Korea between January 2020 and February 2023},
journal = {Virology},
year = {2023},
doi = {10.1016/j.virol.2023.109869}
}
EUVIMED